Skip to main content

Year: 2022

Pet Food Market to Surpass $156.7 Billion by 2028 | Mars Petcare and Nestlé Purina PetCare Generated over $35 billion in 2021

Global pet food market was valued at USD 110.53 Billion in 2021, and it is expected to reach a value of USD 156.57 Billion by 2028, at a CAGR of 5.3% over the forecast period (2022–2028). Westford, USA, Nov. 11, 2022 (GLOBE NEWSWIRE) — Market Overview and Dynamics Pet ownership is on the rise globally, and pet owners are increasingly spending more on their furry friends in the global pet food market. As of 2021, there are more than 950 million pet cats and dogs across the globe. Wherein, the population of dog account for more than 65%. In developed markets such as the United States, Western Europe and Japan, growth will be driven by premiumization, with pet owners willing to spend more on premium products that offer health benefits or meet their pets’ specific needs. In contrast, developing markets such as Brazil and China will...

Continue reading

Diesel Generator Market to Generate Revenue of $25.82 Billion By 2028 | Data Center to Offer Lucrative Growth Opportunity for Diesel Generators

Global diesel generator market was valued at USD 16.89 billion in 2021, and it is expected to reach at USD 25.82 billion by 2028, at a CAGR of 5.5% over the forecast period (2022-2028). Westford, USA, Nov. 11, 2022 (GLOBE NEWSWIRE) — As the world progresses, the demand for energy grows along with it. This increased demand has led to a corresponding increase in the demand for diesel generator market. Diesel generators are a critical part of the power infrastructure and are used in a wide variety of applications, from powering emergency backup systems to providing standby power for data centers. The increased demand for diesel generator market is driven by a number of factors, including population growth, expanding industrialization, and the rise of renewable energy sources. Population growth leads to an increased demand for electricity,...

Continue reading

Global Paints and Coatings Market to Hit Sales of $222.4 Billion By 2028 | Asia Pacific to Generate More than 40% Market Revenue

Global paints and coatings market was valued at USD 150.8 billion in 2021, and it is expected to reach a value of USD 222.4 billion by 2028, at a CAGR of more than 5.5% over the forecast period (2022-2028). Westford, USA, Nov. 11, 2022 (GLOBE NEWSWIRE) — It is no secret that the demands of the modern world are constantly growing. This is especially true when it comes to paints and coatings market. With the ever-increasing popularity of large-scale construction projects, the demand for these products has skyrocketed in recent years. Paints and coatings are used in a wide variety of industries, including construction, automotive, and aerospace. The construction sector is the largest end-user of paints and coatings market, accounting for more than 38% of global demand. The automotive sector is the second-largest end-use market for...

Continue reading

Silo Pharma Achieves New Milestone for SP-26 Therapeutic -Initiates IND Enabling Study of Topical Ketamine Formulation

ENGLEWOOD CLIFFS, NJ, Nov. 11, 2022 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced initial dosing in its IND-enabling study of SP-26, its novel time-released, topical formulation of ketamine. The objective of this safety evaluation study, conducted by Experimur, a Frontage Company, is to evaluate the tolerability of the SP-26 compound to establish a maximum tolerated dose. The new drug is intended to treat fibromyalgia, a chronic condition causing widespread musculoskeletal pain accompanied by memory issues, sleep problems and fatigue. Eric Weisblum, Chief Executive Officer of Silo Pharma, stated, “Our team is excited about this milestone in our collaboration with our joint...

Continue reading

Form 8.5 (EPT/RI) – Hurricane Energy plc

FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)   1.        KEY INFORMATION  (a)        Name of exempt principal trader: Investec Bank plc(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeHurricane Energy plc(c)        Name of the party to the offer with which exempt principal trader is connected: Investec is Joint Broker to Hurricane Energy plc(d)        Date dealing undertaken: 10th November 2022(e)        In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?         If it is a cash offer or...

Continue reading

PyroGenesis Announces Q3 2022 Results: Revenues $5.7M; Gross Margin 73%; Current Backlog of Signed and/or Awarded Contracts $26M

MONTREAL, Nov. 11, 2022 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a high-tech company (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG), is pleased to announce today its financial and operational results for the third quarter ended September 30th, 2022. “In Q3 we delivered another quarter of strong margins against a difficult logistical and inflationary environment for heavy-industry manufacturers and their customers. With our strong production margins firmly established, and our operational and sourcing approaches proven again as not just viable, but sustainable and secure, we can remain squarely focused...

Continue reading

Small Pharma to Participate in November Investor and Healthcare Conferences

LONDON, Nov. 11, 2022 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, is pleased to announce its participation in the following upcoming conferences in November. Jefferies London Healthcare Conference, November 15-17George Tziras, Chief Executive Officer of the Company, will participate in a fireside chat on November 16, 2022 at 4:25 p.m. (GMT) and host investor meetings. To access the webcast, click here to register. To schedule a one-on-one meeting with Small Pharma’s management team, please contact your conference representative or eric@lifesciadvisors.com.CNS Summit, November 17-20, Boca Raton, FloridaDr. Tiffanie Benway will present a poster of the SPL026 Phase...

Continue reading

illimity Ends the Third Quarter of 2022 With Solid Results in Line With Budget Forecasts

Net Profit of 19.1 Million Euro in the Third Quarter of 2022(+21% Q/Q and +2% Y/Y), Which BringsNet Profit to 50.6 Million Euro in 9M22 (+10% vs 9M21) Net Customer Loans at 3.3 Billion Euro (+4% Q/Q and +34% Y/Y) Excellent Asset Quality and Capital Base Confirmed:Organic NPE Ratio1 at 0.7% and CET1 Ratio at 18%2 Net Profit for the Full Year 2022 Expected to beat Least 75 Million Euro With an ROE of Ca. 10% Which Includes Pre-Tax Losses of Approximately 20 Million Euro Arising From the Tech Initiatives – b-ilty, Quimmo, Hype MILAN, Italy, Nov. 11, 2022 (GLOBE NEWSWIRE) — Chaired by Rosalba Casiraghi, the Board of Directors of illimity Bank S.p.A. (“illimity” or the “Bank”) yesterday approved the illimity Group’s results at 30 September 2022. illimity continues its growth path in the third quarter of 2022 as well, with a solid financial...

Continue reading

Onex Reports Third Quarter 2022 Results and Provides Leadership Transition Update

 All amounts in U.S. dollars unless otherwise stated TORONTO, Nov. 11, 2022 (GLOBE NEWSWIRE) — Onex Corporation (TSX: ONEX) today announced its financial results for the third quarter and nine months ended September 30, 2022. The company also provided an update on the intended next step in its leadership transition. “Despite the challenging backdrop, Onex continues to focus on its foundational values of investing in high-quality assets with a long-term perspective and maintaining ample liquidity to take advantage of market cycles,” said Gerry Schwartz, Chairman and Chief Executive Officer of Onex. “Together with a strong culture, deep client relationships and an exceptionally strong balance sheet, we are again positioned to turn market uncertainty into long-term opportunity.” “As we look to the future, I am delighted to announce...

Continue reading

Notice of Shareholders’ Meeting of the Merged EAB Group Plc

EVLI PLC’S STOCK EXCHANGE RELEASE ON NOVEMBER 11, 2022 AT 2.30 P.M. (EET/EEST) EAB Group Plc (“EAB Group”) merged into Evli Plc (“Evli”) on October 1, 2022. Therefore, a notice is given to the shareholders of EAB Group to a Shareholders’ Meeting to be held on Thursday December 8, 2022 at 10:00 a.m. (EET) at the premises of Castrén & Snellman Attorneys Ltd, Eteläesplanadi 14, Helsinki, Finland, to decide on the adoption of the final accounts of the merged company. A. Matters on the agenda of the Shareholders’ Meeting The following matters will be considered at the Shareholders’ Meeting: 1. Opening of the meeting 2. Calling the meeting to order 3. Election of the persons to scrutinise the minutes and to supervise the counting of votes 4. Recording the legality of the meeting 5. Recording the attendance at the meeting and adoption of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.